Channel Synergy Leverage Cytel's global sales network, East Horizon platform and recent acquisitions to deliver integrated HEOR, RWE and trial design services across the pharma pipeline, targeting early to late phase programs.

Payer Ready Evidence Position Purple Squirrel as a provider of robust HEOR/RWE evidence packages and AI-assisted literature reviews (via Nested Knowledge) to support health technology assessments and payer submissions.

Adaptive Trials Offer adaptive trial design and enrichment capabilities to shorten development timelines and reduce costs, aligning with regulatory expectations and using Cytel's statistical expertise.

Boutique Scale Highlight a flexible, high-touch engagement model from a small specialized team, with scalable delivery through Cytel resources to support larger, multi-therapy programs.

Global Reach Capitalize on Cytel's international footprint to win business beyond Massachusetts, expanding into new geographies and therapy areas needing HEOR, RWE and evidence generation.